SOLID TUMOR MALIGNANCY
Clinical trials for SOLID TUMOR MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMOR MALIGNANCY trials appear
Sign up with your email to follow new studies for SOLID TUMOR MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted drug pemigatinib tested in tumors with FGFR mutations – trial stopped early
Disease control TerminatedThis phase 2 study tested the drug pemigatinib in 111 people with advanced solid tumors that have specific FGFR gene mutations or translocations. The goal was to see if the drug could shrink tumors. The trial was terminated early, so the full results are not available.
Matched conditions: SOLID TUMOR MALIGNANCY
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Could a genetic marker guide future cancer therapies in taiwan?
Knowledge-focused TerminatedThis study is measuring how often a specific genetic marker (HLA-A*02:01) and a cancer-related protein (NY-ESO-1) appear in Taiwanese patients with solid tumors like head and neck, liver, lung, breast, and esophageal cancers. By understanding these frequencies, researchers hope t…
Matched conditions: SOLID TUMOR MALIGNANCY
Sponsor: PharmaEssentia • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC